scholarly article | Q13442814 |
P356 | DOI | 10.1080/17482960802192324 |
P698 | PubMed publication ID | 18642137 |
P50 | author | P Nigel Leigh | Q64857298 |
P2093 | author name string | Jeremy M. Shefner | |
P2860 | cites work | Phase II/III randomized trial of TCH346 in patients with ALS | Q28241484 |
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. | Q34584573 | ||
A clinical trial of creatine in ALS. | Q40469445 | ||
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis | Q43569621 | ||
A randomized sequential trial of creatine in amyotrophic lateral sclerosis | Q44383439 | ||
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis | Q44562245 | ||
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study. | Q45296832 | ||
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group | Q46133871 | ||
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial | Q46886269 | ||
P433 | issue | 4 | |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 254-256 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders | Q15759048 |
P1476 | title | Commentary on ‘A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS’ | |
P478 | volume | 9 |
Search more.